The Vessels Shaping Mental Health or Illness

Jugajyoti Baruah1, 2, *, Anju Vasudevan1, 2, *
1 Department of Psychiatry, Harvard Medical School, Boston, MA-02215, USA
2 Angiogenesis and Brain Development Laboratory, Division of Basic Neuroscience, McLean Hospital, 115 Mill Street, Belmont, MA-02478, USA

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 219
Abstract HTML Views: 183
PDF Downloads: 125
ePub Downloads: 106
Total Views/Downloads: 633
Unique Statistics:

Full-Text HTML Views: 147
Abstract HTML Views: 106
PDF Downloads: 92
ePub Downloads: 72
Total Views/Downloads: 417

© 2019 Baruah et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: ( This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to these author at the Harvard Medical School and McLean Hospital, 115 Mill St, Belmont, MA-02478, USA; Tel: 617-855-2049; Fax: 617-855-3747; E-mails: or


The mammalian brain receives the lion’s share of the body’s blood supply and is a highly vascularized organ. The vascular and nervous systems arise at two distinct time points of embryogenesis; however, their functions tend to overlap or complement each other in the growth promoting milieu of the embryonic Central Nervous System (CNS). The pre-existing idea that mental disorders are a direct result from defects solely in neuronal populations and networks is gradually changing. Several studies have implicated blood vessel pathologies and blood flow changes in mental health disorders. Our own studies provide new perspectives as to how intrinsic defects in periventricular endothelial cells, from the earliest developmental time points can lead to the origin of mental health disorders such as schizophrenia, autism spectrum disorders (ASD), anxiety, and depression, thereby establishing direct links. In this article, we provide an overview of how the endothelial cell compartment in the brain is now gaining attention in the context of mental health disorders.

Keywords: Brain, Blood vessel, Endothelial cell, Mental health, Psychiatric disorders.


The most recent report by The Lancet Commission highlighted the global burden of mental health disorders revealing staggering numbers and a prediction for a rapid increase in the number of individuals with a mental health problem [1,2]. It is currently known that an estimate of 1 in 4 people worldwide is affected by one or the other form of mental disorder [3]. Mental health disorder can manifest as schizophrenia, autism spectrum disorder (ASD), anxiety or depression. Most of these illnesses affect multiple functions of the brain and are only partially responsive to therapeutic interventions or pharmacological treatments. The pathological processes involved in the emergence of the phenotype have mostly been ‘neurocentric’. This neurocentric focus implies that defects or malfunctioning in the biology of neurons includes but not limited to neurotransmitter system dysfunctions; primarily the Gamma Aminobutyric Acid (GABA)ergic, dopaminergic or glutamatergic systems, myelin, immune response, infectious reagents or idiopathic reasons [4,5]. However, none of these have accounted for the heterogeneous array of symptoms displayed by the affected individual, thereby making therapeutic intervention only partially successful. But, over the years, this ‘neurocentric’ idea is gradually shifting focus to the contribution of non-neuronal cells, such as the Endothelial Cells (ECs) lining the blood vessels. In a span of 40 years, there has been a sparse yet tangential increase in the number of reports documenting the role of blood vessels in the pathophysiology of mental health disorders (Fig. 1).

As the number of studies highlighting a potential correlation between blood vessel changes in mental health disorders begins to increase, and we know that there is a cross-talk between the developing vasculature and neuronal populations, it is important to question whether defects in the blood vessel system are a cause or an effect in the etiology of mental health disorders? Here we provide a concise overview of studies reporting defects in brain vascular beds that might have long term implications in the proper functioning and physiological activities of the brain. We describe new conceptual advances that primary defects in the blood vessels of the developing brain can act directly to cause a mental health condition. A greater understanding of the macro and micro vascular alterations in mental health disorders at different stages of life will serve to initiate the use of vascular units as potential therapeutic targets in the future.

Fig. (1). An increasing trend observed in the numbers of endothelial related publications in A) Schizophrenia Β) Autism C) Depression D) Anxiety and E) Mental Health. The PubMed database was searched from January 01st, 1977 to December 31st for each consecutive year until September 2018. All articles that were selected by the search hit were included.

1.1. A Historical Overview

Prior to the 18th century, an individual presenting signs of ill mental health had to undergo different forms of social and physical abuse. At the turn of the 18th century or the ‘Enlightenment Era’, psychological disorders were commonly referred to as the ‘nervous disorders’ and ‘neurosis’, meaning, a disorder primarily associated with the nervous system. While this paved the way to define a biological as opposed to a supernatural or psychological cause for the symptoms associated with a mental health disorder, it took another century for the physicians, and the psychologists, to comprehend that mental health disorders are not a direct consequence of a malfunctioned nervous system. Given the diagnostic complexities, high comorbidity, and indistinct boundaries that define mental health disorders, it became increasingly evident that the symptoms associated with mental health disorders are multifactorial and not just neurocentric. Among such factors, the foremost is the cellular heterogeneity of the mammalian brain, which in part is responsible for the complex array of symptoms in patients with mental health disorders. The mammalian brain in highly heterogeneous at the cellular level and has a significant percentage of non-neuronal cells [6]. Among the non-neuronal cell population, a major regulator of brain homeostatic function as well as forming the blood-brain barrier (BBB) system is the blood vessels formed of Endothelial Cells (ECs).

Historically, the blood vessels were thought to serve as conduits to deliver nutrients and oxygen to the target tissues, including the brain [7]. Because the brain is a metabolically active organ and is dependent on the blood vessels for its metabolic needs, it is very important that the proper foundation of the brain vasculature is laid during the embryonic stages. An improper patterning of the developing blood vessels can imprint long lasting effects on the proper functioning of the brain and therefore the individual [8,9]. This process of vascularization is accomplished by a well-coordinated, spatiotemporal multistep process called angiogenesis. Angiogenesis is a process whereby ECs proliferate and migrate, to establish vascular networks in target tissues [10,11]. In the context of the mammalian brain, angiogenesis is classified as developmental, physiological or pathological [9]. Developmental angiogenesis orchestrates the spatiotemporal arrangement of the complex CNS vascular networks [12]. Physiological angiogenesis occurs during embryonic development as well as during postnatal growth of the individual to accommodate the growing energy needs. Pathological angiogenesis primarily occurs during adulthood triggered by certain insults/injury, malignant transformation or idiopathic reasons that activate ECs.

In this context, the earliest evidence suggesting observations of vascular abnormalities in the pathophysiology of a mental disorder such as Schizophrenia (SZ) was demonstrated by the work of Bleuler et al. utilizing post mortem brain samples [13]. Following this idea, a significant amount of work has been conducted to explain and unify physiological abnormalities of the brain vasculature in other mental disorders (Fig. 2). In addition to defects in angiogenesis, a second common occurrence associated with mental disorders is the disruption of the Blood Brain Barrier (BBB) system. The BBB is an excellent barrier protecting the brain from toxic metabolites, infectious agents and thereby regulating brain homeostasis. At the forefront, ECs are a vital component of the BBB, which have also been studied in the context of mental health disorders. Seminal findings focused on alterations in the BBB came from a simple and small study conducted on veterans that displayed symptoms associated with ill mental health [14]. The patients were administered trace amounts of ions, and later the cerebrospinal fluid and blood were withdrawn to measure the amount of distribution. Alterations in the permeability of the BBB was observed and it was postulated that it might be a ‘metabolic defect’ [14]. But, it was unclear whether changes in the BBB permeability led to symptoms of the psychotic disorders. Thereafter, with improved imaging techniques such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and application of cellular and molecular biology techniques, several different hypotheses were proposed regarding the BBB physiology in mental health disorders. Below, we provide a brief summary of different reports that highlight a potential link between changes in blood vessel function per se angiogenesis and/or BBB alterations along with molecular evidence in support of different mental health disorders.

1.2. Blood Vessel Dysfunction in Schizophrenia and Epilepsy

Schizophrenia (SZ) is one of the most debilitating mental health disorders and the etiology has remained largely elusive. Following the foundation work by Bleuler et al. [13], researchers have tried to focus on understanding the complex interactions between angiogenic factors and neurotrophic factors during development, alterations in blood vessels structure and function, as well as the changes in the BBB. Utilizing the Xenon Xe-133 inhalation method or PET scans, it was observed that most of them displayed hypofrontality, with abnormalities in the hemodynamics of the brain [15,16]. This hypofrontality is consistent with frontal hypoperfusion, meaning, reduced number of vessels in the frontal cortex, which is seen in various regions of the brain. Interestingly, inflow-based-vascular-space-occupancy (iVASO) MRI imaging evaluations have further shown that vessels on the pial surface and arterioles have significant microvascular anomalies and are widespread in the entire brain of a schizophrenic patient [17]. It is postulated that this hypoperfusion accounts for a reduced Cerebral Blood Flow (rCBF), which has been associated with psychotic symptoms [18]. We believe that a reduced vessel number can stem from defects in angiogenesis during early developmental stages, that might result in impaired branching or vessel maturation, and may serve as a possible explanation for the reduced CBF associated with the brains of SZ patients. In parallel, to support the contributions of BBB disruption in the etiology of SZ, post mortem morphometric analyses of prefrontal and visual cortices of SZ individuals showed the presence of ultrastructural abnormalities of capillaries such as thickening of the basal lamina and cytoplasmic vacuolation of ECs [19]. At the molecular level, pathway analysis revealed that most of the well-established angiogenesis-related pathway genes such as Wnt, VEGF, IGF-1, Oncostatin-M, angiopoietin, ephrin-receptor signaling etc., were downregulated in the brain regions of individuals with SZ [18].

Another important consideration in SZ is the co-symptomatic presence of epilepsy. Blood vessel changes in the etiology of temporal lobe epilepsy were first demonstrated in a morphological study utilizing surgically resected tissue samples by Hamada et al. in 1976 [20]. A decade later, ultrastructural analysis of the BBB showed an increased micropinocytosis in the capillaries during seizures [21]. These were one of the many earlier evidences indicating alterations in the vasculature, especially in the BBB in human psychomotor epilepsy. An increase in interendothelial junctions localized to the seizure-specific regions in the brain was also observed. With the availability of advanced tools and imaging techniques, and a continued interest in vascular contribution towards epilepsy, studies were conducted that highlighted the role of vascular remodeling and angiogenic processes in temporal lobe epilepsy [22,23]. Multiple molecular and cellular mechanisms have been proposed to be involved in the emergence of epilepsy [24,25]. In this context, Vascular Endothelial Growth Factor (VEGF) and its receptors have been studied extensively, highlighting potential mechanisms of how VEGF/VEGFR2 pathway leads to a disruption of BBB in epilepsy [26,27]. VEGF is a key signaling molecule and secreted growth factor in the central nervous system where it mediates angiogenesis, neuroprotection, neuronal survival, and axonal outgrowth. One of the proposed mechanisms involving VEGF is that an epilepsy episode leads to an increased expression of VEGF, which in turn promotes angiogenesis, and increases vascular permeability. Another important pathway implicated in epilepsy is the Ephrin-A5/EphrinA4 pathway, which modulates angiogenesis via the activities of phosho-Akt and phosho-ERK [28].

In addition to this, studies conducted using chemoconvulsive rat models administered with kainate and pilocarpine emphasized a strong correlation between vascular damage and astroglial function. Astrocytic lesions in the specific Cornu Ammonis 3 (CA3) and Piriform (Pir) cortex regions of the brain were significantly related to blood vessel damage in these areas [29,30]. Especially in the CA3 region, this damage and subsequent remodeling may deeply affect the hippocampal response to inputs from dentate gyrus and entorhinal cortex. This damage was accompanied by microhemorrhages and loss of vessel integrity that is often seen in cerebral ischemia leading to hypoxic conditions. Such studies once again underscore the importance of vascular function in the pathophysiology of epilepsy [29,30]. Through this evidence, one may theorize that vascular protection during epilepsy may ameliorate the ischemic effects in specific brain regions. To this end, a recent study conducted by Vinet et al. showed that experimental use of a matrix metalloprotease (MMP) inhibitor-12 limited ischemic-like lesion formation in the hippocampus of a pilocarpine-induced rat model of epilepsy by reducing BBB leakage at the lesion site [31]. Even though the studies till date have improved our understanding of vascular changes in mental health disorders, there are significant and important questions that remain to be addressed.

1.3. Blood Vessel Dysfunction in Autism Spectrum Disorders (ASD)

Herold S. measured the regional cerebral blood flow along with oxygen and glucose consumption using PET imaging in young autistic adults. While this was the first kind of a study trying to link blood vessel function such as cerebral blood flow (CBF) to autism, he was not able to report any significant differences between healthy controls and autistic individuals [32]. Later, an extensive work conducted by Zilbovicius et al., utilized Single Photon Emission Computed Tomography (SPECT) imaging and observed a potential link between delayed CBF in the frontal lobe of autistic children [33]. These studies showed that delayed metabolic maturation of the frontal lobes arising from hypoperfusion might constitute an important link between cognitive defects and brain dysfunction in childhood autism. Due to this hypoperfusion, the neuronal connections are altered in the brain affecting overall neural network formation and brain development. One of the many causes for this reduced blood flow to the cerebral cortex was proposed as endothelial inflammation or endothelial dysfunction. Another important correlation was the expression of vascular endothelial growth factor (VEGF) and its endogenous antagonists, soluble VEGF receptors (sVEGFR)-1 and -2. In subjects with severe ASD, a lower level of VEGF and increased sVEGFR-1 in the serum were reported [34]. This reduced expression of VEGF can account for a decrease in angiogenesis, therefore reduced number of vessels or hypoperfusion of the brain, which supports the link between decreased cerebral blood flow and ASD. Additionally, expression levels of serum platelet endothelial cell adhesion molecule (PECAM)-1, soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble P-selectin were significantly reduced in children with ASD [35,36]. Interestingly, a more recent immunocytochemical staining of post-mortem brain slices has revealed persistent angiogenesis in the child and young adult patients with ASD, where blood vessels are in constant flux rather than expanding [37] and highlights that blood vessel plasticity is a global component of the ASD brain. In this study, the authors propose that repetitive seizures, a common symptom associated with ASD patients, cause an increase in the brain activity which then leads to splitting or intussusceptive angiogenesis that further guides neuronal rearrangement. This rearrangement of the microvasculature allows for the excessive and shorter local connectivity within the neurons, which then prevents the growth of longer and more complex brain connections required for language and social interactions. In a small yet significant study, Bashir & Ayadhi [2015] reported an increase in anti-endothelial antibody levels in the sera of children with autism [38]. Although studies as such will require validation with a larger cohort and with molecular methodologies, the alteration of the blood vessel environment in ASD is evident.

1.4. Blood Vessel Dysfunction in Depression and Anxiety

In an attempt to highlight the importance of blood vessels in depression, Alexopoulus et al. proposed the “Vascular Depression hypothesis” that summarized clinical studies of how patients with vascular disease such as hypertension, ischemic heart disease, peripheral vascular disease, stroke, heart failure, coronary artery disease and vascular dementia, often have depression [39] and questioned whether the damage of vascular structures contributed to depression in geriatric patients? Today, as we know, depression affects an individual irrespective of age. As investigators continue to understand the biological basis of depression, it is clear that blood vessel health is of significance in people suffering from depression. Importantly, the phenotypes associated with depression are multivariate, and therefore, there exists a causal relationship between depression and anxiety. The understanding of how dysfunction of the blood vessel component might be important in these two forms of psychological disorders is very recent compared to other extensively studied forms of mental health disorders.

Fig. (2). Schema highlighting vascular processes affected in mental health disorders. The brain vascular network which is comprised of endothelial cells can undergo perturbations at multiple levels such as response to inflammatory molecules in circulation, altered plasticity depending on the cellular environmental conditions or changes in the cerebral blood flow (hypoperfusion). Others such as EC dysfunction or EC-derived signaling events can also give rise to disease phenotypes.

An interesting feature of depression related disorder and its subtypes is that, often times, depression is more prevalent in patients with Coronary Artery Disease (CAD) [40], where patients exhibit abnormal endothelial function. Several post mortem analyses of the orbitofrontal cortex and other regions of the elderly patients with major depressive disorder (MDD) showed morphological changes in the vascular structure, specifically an increase in perivascular spaces and increased intracellular cell adhesion molecule-1 (ICAM-1) [41,42]. Importantly, a correlative study using a rat model of depression revealed impaired function of the endothelium-derived hyperpolarizing (EDH)-like relaxation factor in small resistance arteries [43]. At the molecular level, the expression of several key endothelial cell molecules such as IGF1, VEGF, VEGF-A is altered in patients with depression [44,45]. Moving forward from the vascular depression hypothesis, a most recent review by Burrage et al. clearly highlight the potential role of cerebrovascular dysfunction in depression, along with some key molecules such as VEGF, nitric oxide (NO), and thrombospondin-1 (TSP-1), that might have implications in exacerbating the phenotype [46]. It was found that patients exhibiting subclinical depressive status without any evident CVD had a low number of circulating endothelial progenitor cells (EPC) or an altered vascular function [47,48]. In addition, using high resolution imaging of the retinal vasculature, certain associations have been made between the retinal microvasculature and/or endothelial function, such as flow-mediated dilation in young and adolescent patients, where the authors propose that alterations of the microvasculature at an early age predispose individuals to develop either depression and anxiety [49,50]. Another important criterion of endothelial cell function such rCBF was significant in various areas of the brain [51]. As it is a well-established phenomenon that hypoperfusion leads to psychomotor retardation and impaired executive function, therefore it is not surprising that an impairment of blood vessel function is seen during depression and/or anxiety. At the molecular level, activation of GABAB2 which increases cerebral hypoperfusion leads to the development of anxiety-like behaviors in a rodent model of cerebral ischemia [52].

Together, all these studies provide insights into alterations in vascular pathology, disturbances in cerebral blood flow or abnormalities in blood vessel function in post-mortem samples, rodent models and patients with the use of old and new technologies. Several of these vascular disturbances are linked to inflammation or changes in neural plasticity at various stages of life. We have summarized the various vascular abnormalities reported in mental disorders into a schema (Fig. 2). However, these studies do not clearly implicate abnormalities in vessels as a direct cause for the disease. Recent studies in our laboratory provide new insights into this direction.

1.5. The Vascular Origin of Mental Health Disorders

In the last decade, our work has made significant conceptual advances with respect to CNS angiogenesis from developmental and disease perspectives [53-56]. The change began with the finding that blood vessels in the embryonic forebrain (telencephalon) are not just a homogenous population of vessels, responding passively to the metabolic demands of growing neuronal populations [53]. Based on anatomy, origin, gene expression patterns and developmental mechanisms, there are two distinct telencephalic vascular networks pial and periventricular. The tapering vessels joining the periventricular and pial vessels may represent the earliest arterial-venous communication. The periventricular vascular network develops in advance of and independent of neuronal development by embryonic day 11 to act as a substrate and provide critical guidance cues to instruct key events that follow in the embryonic telencephalon, for instance, neurogenesis, radial migration of projection neuron precursors and tangential migration of GABAergic interneurons [54,55]. The pial and periventricular vascular networks provide separate guidance cues to the superficial stream of GABAergic interneurons in the Marginal Zone (MZ) versus the deep stream of GABAergic neurons in the Subventricular Zone (SVZ) during long distance tangential neuronal migration (Fig. 3A). We have summarized important markers that are specific to periventricular endothelial cells versus pial endothelial cells and common markers that identify both cell types (Fig. 3B). Interestingly, the periventricular vascular network not only acts as a physical substrate for neuronal migration but also it holds the key to several novel developmental mechanisms and pathways [54-56]. Gene expressions for biological processes and canonical maps containing genes controlling neurogenesis, neuronal migration, chemotaxis, and axon guidance were enriched in periventricular endothelial cells when compared to pial endothelial cells. For instance, genes commonly known to be expressed and/or traditionally believed to be confined to GABAergic neurons/interneurons and their precursors were found to be expressed/even upregulated in periventricular endothelial cells. Pial endothelial cells, on the other hand, showed enrichment in inflammation and pathological process categories. When genes expressed in periventricular endothelial cells were classified according to disease categories, an enrichment was observed in psychiatric disease categories [55]. Our studies thus implicated a new cellular substrate periventricular endothelial cells as being a contribution to a wide swath of mental health diseases with schizophrenia, epilepsy, bipolar, mood, depressive disorders and autism topping the list [55]. These results also highlighted the great need to validate and understand the functional significance of novel genes expressed in periventricular endothelial cells/blood vessels and its specific contribution to psychiatric disease symptoms.

This, however, was not an easy task. All the mouse models reported until now are complete/systemic or region specific knockouts of the GABAA receptor-GABA pathway making it difficult to establish a cause-effect relationship between endothelial and neuronal development and cell-type specific contributions to the origin of neuropsychiatric illness. To discover the functional significance of the endothelial GABA signaling pathway from early developmental stages onward, we designed strategies to specifically render endothelial GABAA receptors dysfunctional (the Gabrb3 endothelial cell conditional knockout or Gabrb3 ECKO) or turn off GABA release from endothelial cells (the Vesicular GABA Transporter, Vgat) endothelial cell conditional knockout or Vgat ECKO) by using CRE-LOX conditional gene knockout technology [56]. Both approaches markedly affected periventricular angiogenesis throughout prenatal development. Reduction in this vascular substrate, in turn impaired GABAergic neuronal tangential migration, albeit more severely in the Vgat ECKO model versus the Gabrb3 ECKO model (Fig. 3C-E). Concurrent vascular and GABA cell deficits persisted in the postnatal cerebral cortex with significant consequences for postnatal behavior [56]. Partial loss of endothelial GABA release was sufficient to cause behavioral dysfunction similar to the psychiatric disease that is characterized by one or more of these core symptoms - impaired social recognition, reduced social interactions, communication deficits, increased anxiety or depression. Complete loss of GABA release resulted in significant abnormalities in developmental milestones and resulted in a model reminiscent of childhood epilepsy or ASD. Alterations in postnatal behavior were characterized by periods of quiescence, interrupted by tremors and a reduction in voluntary movement and the mice failed to survive beyond 2 months of age. Our studies for the first time, describe how intrinsic defects within telencephalic vasculature/endothelial cells from the earliest developmental time points can independently mold neuronal signaling pathways with far-reaching consequences for brain development and behavior [56]. It also highlights a vascular GABA signaling pathway that is distinct from the neuronal GABA signaling and how variations in vascular GABA levels can cause diversity in psychiatric symptoms.

Fig. (3). (A) Schema depicting selective sorting of superficial stream of GABAergic interneurons in the MZ by pial vessels and deep stream of GABAergic interneurons in the SVZ by the periventricular vessels of the embryonic telencephalon [E13]. (B) A table depicting some important markers that distinguish periventricular endothelial cells from pial endothelial cells in the embryonic telencephalon. Common markers expressed in pial and periventricular endothelial cells are also shown. (C-E) Schema depicting conceptual changes in GABA signaling during brain development. (C) Wildtype embryonic telencephalon with normal periventricular vascular network (red lattice pattern) and normal endothelial GABA signaling pathway (reddish-orange hue) promotes tangential GABAergic neuronal migration (green) from the ventral telencephalon. (D) In Gabrb3 ECKO telencephalon, which has dysfunctional endothelial GABAA receptors, there is a partial loss of endothelial GABA secretion (light orange hue). This affects periventricular angiogenesis (intricate red pattern) and neuronal migration with a reduction in GABAergic interneurons in the developing neocortex. (E) In Vgat ECKO telencephalon, there is a complete loss of endothelial GABA secretion (light yellowish hue) that affects periventricular angiogenesis (dotted red pattern) with more significant consequences for GABAergic neuronal migration resulting in abnormal cortical distribution.


The present review aims to provide an overview of progressive research in understanding the contribution of blood vessel anomalies in mental illness. The advances that took place were sparse and heterogeneous over the past forty years (Fig. 1), which suggest that endothelial cell contribution to the pathophysiology of mental illness was an underappreciated area of research. Most of the initial derivations were based on observations from structural studies and anatomical anomalies in patients exhibiting one or the other form of mental illness. However, over the next several decades, seminal observations by various investigators shifted this idea and emphasized the presence of vascular abnormalities in mental illnesses. Our own studies show how alterations in a novel GABA pathway in endothelial cells can contribute to the origin of mental health disorders [55,56].

It is interesting that exercise and spiritual activities like meditation, are often recommended for improvement of mental health. Both activities have beneficial effects on the brain by triggering angiogenesis and blood flow that in turn improve cognitive performance [57,58]. However, if there is an intrinsic defect within brain blood vessels, such options may not work. A better understanding of the spatiotemporal regulation of EC gene expression and function in brain vascular networks at both developmental and adult stages in normal and disease conditions is critical for the future. We hope that the ‘healing touch’ of angiogenesis therapy that has brought relief to patients with stroke, blinding eye diseases, cancer and neurodegeneration will gradually extend to the field of mental health disorders over the next years. Determination of brain blood vessel health should become a part of our routine health visits and check-ups.


Not applicable.


The authors declares no conflict of interest, financial or otherwise.


This research is supported by the National Institute of Mental Health (R01MH110438) and National Institute of Neurological Disorders and Stroke (R01NS100808) grants to AV.


[1] Hancock M. Prevention, detection, intervention: the big wins for mental health. Lancet 2018; 392(10157): 1499-500.
[2] Frankish H, Boyce N, Horton R. Mental health for all: a global goal. Lancet 2018; 392(10157): 1493-4.
[3] Ginn S, Horder J. “One in four” with a mental health problem: the anatomy of a statistic. BMJ [Internet] 2012; 344: e1302.
[4] Stevens HE, Smith KM, Rash BG, Vaccarino FM. Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders. Front Neurosci 2010; 4: 59.
[5] Marín O. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci 2012; 13(2): 107-20.
[6] Herculano-Houzel S. The human brain in numbers: a linearly scaled-up primate brain. Front Hum Neurosci 2009; 3: 31.
[7] Nachman RL. Endothelium: from cellophane to orchestral maestro. J Clin Invest 2012; 122(3): 796-7.
[8] Lee HS, Han J, Bai H-J, Kim K-W. Brain angiogenesis in developmental and pathological processes: regulation, molecular and cellular communication at the neurovascular interface. FEBS J 2009; 276(17): 4622-35.
[9] Vallon M, Chang J, Zhang H, Kuo CJ. Developmental and pathological angiogenesis in the central nervous system. Cell Mol Life Sci 2014; 71(18): 3489-506.
[10] Risau W. Mechanisms of angiogenesis. Nature 1997; 386(6626): 671-4.
[11] Plate KH. Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 1999; 58(4): 313-20.
[12] Vasudevan A, Bhide PG. Angiogenesis in the embryonic CNS: a new twist on an old tale. Cell Adhes Migr 2008; 2(3): 167-9.
[13] Schizophrenia as described by Bleuler. Cincinnati J Med 30(8)
[14] Barber RM, Lafferty CR. The blood-brain barrier in neuropsychiatric disorders. J Med Assoc State Ala 1957; 26(11): 291-4.
[15] Berman KF, Zec RF, Weinberger DR. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry 1986; 43(2): 126-35.
[16] Andreasen NC, O’Leary DS, Flaum M, et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet 1997; 349(9067): 1730-4.
[17] Hua J, Brandt AS, Lee S, et al. Abnormal Grey Matter Arteriolar Cerebral Blood Volume in Schizophrenia Measured With 3D Inflow-Based Vascular-Space-Occupancy MRI at 7T. Schizophr Bull 2017; 43(3): 620-32.
[18] Katsel P, Roussos P, Pletnikov M, Haroutunian V. Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection. Neurosci Biobehav Rev 2017; 77: 327-39.
[19] Uranova NA, Zimina IS, Vikhreva OV, Krukov NO, Rachmanova VI, Orlovskaya DD. Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J Biol Psychiatry 2010; 11(3): 567-78.
[20] Hamada H, Kobayashi E, Mihara T, Asakura T, Kitamura K. A morphological study on vascular changes in the surgically resected tissues of temporal lobe epilepsy-with a special reference to the etiology. Folia Psychiatr Neurol Jpn 1976; 30(3): 435-53.
[21] Cornford EM, Oldendorf WH. Epilepsy and the blood-brain barrier. Adv Neurol 1986; 44: 787-812.
[22] Rigau V, Morin M, Rousset M-C, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007; 130(Pt 7): 1942-56.
[23] Ndode-Ekane XE, Hayward N, Gröhn O, Pitkänen A. Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy. Neuroscience 2010; 166(1): 312-32.
[24] Pitkänen A, Lukasiuk K. Molecular and cellular basis of epileptog-enesis in symptomatic epilepsy. Epilepsy Behav 2009; 14(1)(Suppl. 1): 16-25.
[25] Librizzi L, de Cutis M, Janigro D, et al. Cerebrovascular heterogeneity and neuronal excitability. Neurosci Lett 2018; 667: 75-83.
[26] Croll SD, Ransohoff RM, Cai N, et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 2004; 187(2): 388-402.
[27] Nikitidou L, Kanter-Schlifke I, Dhondt J, Carmeliet P, Lambrechts D, Kokaia M. VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures. PLoS One 2012; 7(7): e40535.
[28] Shu Y, Xiao B, Wu Q, et al. The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE. Mol Neurobiol 2016; 53(1): 561-76.
[29] Gualtieri F, Curia G, Marinelli C, Biagini G. Increased perivascular laminin predicts damage to astrocytes in CA3 and piriform cortex following chemoconvulsive treatments. Neuroscience 2012; 218: 278-94.
[30] Lucchi C, Vinet J, Meletti S, Biagini G. Ischemic-hypoxic mechanisms leading to hippocampal dysfunction as a consequence of status epilepticus. Epilepsy Behav 2015; 49: 47-54.
[31] Vinet J, Costa A-M, Salinas-Navarro M, et al. A Hydroxypyrone-Based Inhibitor of Metalloproteinase-12 Displays Neuroprotective Properties in Both Status Epilepticus and Optic Nerve Crush Animal Models. Int J Mol Sci 2018; 19(8): 2178.
[32] Herold S, Frackowiak RS, Le Couteur A, Rutter M, Howlin P. Cerebral blood flow and metabolism of oxygen and glucose in young autistic adults. Psychol Med 1988; 18(4): 823-31.
[33] Zilbovicius M, Garreau B, Samson Y, et al. Delayed maturation of the frontal cortex in childhood autism. Am J Psychiatry 1995; 152(2): 248-52.
[34] Emanuele E, Orsi P, Barale F, di Nemi SU, Bertona M, Politi P. Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism. Clin Biochem 2010; 43(3): 317-9.
[35] Onore CE, Nordahl CW, Young GS, Van de Water JA, Rogers SJ, Ashwood P. Levels of Soluble Adhesion Molecules PECAM-1 and P-Selectin are Decreased in Children with Autism Spectrum Disorder. Biol Psychiatry 2012; 72(12): 1020-5.
[36] Kameno Y, Iwata K, Matsuzaki H, et al. Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder. Mol Autism 2013; 4(1): 19-9.
[37] Azmitia EC, Saccomano ZT, Alzoobaee MF, Boldrini M, Whitaker-Azmitia PM. Persistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum. J Autism Dev Disord 2016; 46(4): 1307-18.
[38] Bashir S, Al-Ayadhi L. Endothelial antibody levels in the sera of children with autism spectrum disorders. J Chin Med Assoc 2015; 78(7): 414-7.
[39] Alexopoulos GS, Bruce ML, Silbersweig D, Kalayam B, Stern E. Vascular depression: a new view of late-onset depression. Dialogues Clin Neurosci 1999; 1(2): 68-80.
[40] Januzzi JL, Pasternak RC. Depression, hostility, and social isolation in patients with coronary artery disease. Curr Treat Options Cardiovasc Med 2002; 4(1): 77-85.
[41] Thomas A, Ferrier I, Kalaria R, Perry R, Brown A, O’Brien J. A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry ; 70(1): 83-7.
[42] Miguel-Hidalgo JJ, Jiang W, Konick L, et al. Morphometric analysis of vascular pathology in the orbitofrontal cortex of older subjects with major depression. Int J Geriatr Psychiatry 2013; 28(9): 959-70.
[43] Bouzinova EV, Norregaard R, Boedtkjer DMB, et al. Association between endothelial dysfunction and depression-like symptoms in chronic mild stress model of depression. Psychosom Med 2014; 76(4): 268-76.
[44] Kahl KG, Bens S, Ziegler K, et al. Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinology 2009; 34(3): 353-7.
[45] Sharma AN, da Costa e Silva BF, Soares JC, Carvalho AF, Quevedo J. Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies. J Affect Disord 2016; 197: 9-20.
[46] Burrage E, Marshall KL, Santanam N, Chantler PD. Cerebrovascular dysfunction with stress and depression. Brain Circ 2018; 4(2): 43-53.
[47] Hemingway H, Shipley M, Mullen MJ, et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol 2003; 92(8): 984-7.
[48] Chen H, Yiu KH, Tse HF. Relationships between vascular dys-function, circulating endothelial progenitor cells, and psychological status in healthy subjects. Depress Anxiety 2011; 28(8): 719-27.
[49] Nguyen TT, Wong TY, Islam FMA, et al. Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression. Psychosom Med 2010; 72(6): 535-8.
[50] Meier MH, Gillespie NA, Hansell NK, et al. Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults. Psychosom Med 2014; 76(9): 732-8.
[51] Ho TC, Wu J, Shin DD, et al. Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. J Am Acad Child Adolesc Psychiatry 2013; 52(10): 1076-1091.e2.
[52] Lu Y, Li CJ, Chen C, et al. Activation of GABAB2 subunits alleviates chronic cerebral hypoperfusion-induced anxiety-like behaviours: A role for BDNF signalling and Kir3 channels. Neuropharmacology 2016; 110(Pt A): 308-21.
[53] Vasudevan A, Long JE, Crandall JE, Rubenstein JLR, Bhide PG. Compartment-specific transcription factors orchestrate angiogenesis gradients in the embryonic brain. Nat Neurosci 2008; 11(4): 429-39.
[54] Li S, Haigh K, Haigh JJ, Vasudevan A. Endothelial VEGF sculpts cortical cytoarchitecture. J Neurosci 2013; 33(37): 14809-15.
[55] Won C, Lin Z, Kumar T P, et al. Autonomous vascular networks synchronize GABA neuron migration in the embryonic forebrain. Nat Commun 2013; 4: 2149.
[56] Li S, Kumar T P, Joshee S, et al. Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior. Cell Res 2018; 28(2): 221-48.
[57] Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. Neuroreport 2005; 16(17): 1893-7.
[58] Morland C, Andersson KA, Haugen OP, et al. Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1. Nat Commun 2017; 8: 15557.